Wenzhou Medical University Affiliated First Hospital

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm	Recruiting	Phase 3	2026-06-25	NCT07385703
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)	Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Phase 3	2026-05-29	NCT07165951
A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma	gastroesophageal adenocarcinoma	Recruiting	Phase 2	2025-07-30	NCT06767800

Clinical trials